{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:17:31Z","timestamp":1791983851605,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10787-026-02265-8","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:51:57Z","timestamp":1779537117000},"page":"4017-4030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-4926","authenticated-orcid":false,"given":"Nazila","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0250-729X","authenticated-orcid":false,"given":"Homayoun","family":"Pishraft-Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1797-8985","authenticated-orcid":false,"given":"Rayhaneh","family":"Gol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-2506","authenticated-orcid":false,"given":"Dorsa","family":"Najari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2809-3091","authenticated-orcid":false,"given":"Sara","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-8814","authenticated-orcid":false,"given":"Amirhossein","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-1005","authenticated-orcid":false,"given":"Hamidreza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"5","key":"2265_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/hep.24802","volume":"55","author":"A Ambade","year":"2012","unstructured":"Ambade A, Catalano D, Lim A, Mandrekar P (2012) Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology 55(5):1585\u20131595","journal-title":"Hepatology"},{"issue":"12","key":"2265_CR2","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-09-0152","volume":"15","author":"R Bao","year":"2009","unstructured":"Bao R, Lai CJ, Qu H, Wang D, Yin L, Zifcak B et al (2009) CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy. Clin Cancer Res 15(12):4046\u20134057","journal-title":"Clin Cancer Res"},{"key":"2265_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128897","volume":"14","author":"H Ben Abdallah","year":"2023","unstructured":"Ben Abdallah H, Seeler S, Bregnh\u00f8j A, Ghatnekar G, Kristensen LS, Iversen L, Johansen C (2023a) Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation. Front Immunol 14:1128897","journal-title":"Front Immunol"},{"key":"2265_CR4","doi-asserted-by":"publisher","first-page":"1289788","DOI":"10.3389\/fimmu.2023.1289788","volume":"14","author":"H Ben Abdallah","year":"2023","unstructured":"Ben Abdallah H, Bregnh\u00f8j A, Ghatnekar G, Iversen L, Johansen C (2023b) Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action. Front Immunol 14:1289788","journal-title":"Front Immunol"},{"issue":"1","key":"2265_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamadermatol.2023.4800","volume":"160","author":"H Ben Abdallah","year":"2024","unstructured":"Ben Abdallah H, Bregnh\u00f8j A, Emmanuel T, Ghatnekar G, Johansen C, Iversen L (2024) Efficacy and safety of the heat shock protein 90 inhibitor RGRN-305 in Hidradenitis Suppurativa: a parallel-design double-blind trial. JAMA Dermatol 160(1):63\u201370","journal-title":"JAMA Dermatol"},{"key":"2265_CR6","doi-asserted-by":"publisher","unstructured":"Ben Abdallah H, Bregnh\u00f8j A, Emmanuel T, Bertelsen T, Dudink K, van Straalen KR et al.  (2025) Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 39(8):e685\u20138. https:\/\/doi.org\/10.1111\/jdv.20468IF","DOI":"10.1111\/jdv.20468IF"},{"issue":"5","key":"2265_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/bjd.20880","volume":"186","author":"A Bregnh\u00f8j","year":"2022","unstructured":"Bregnh\u00f8j A, Thuesen KKH, Emmanuel T, Litman T, Grek CL, Ghatnekar GS et al (2022) HSP90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study. Br J Dermatol 186(5):861\u2013874","journal-title":"Br J Dermatol"},{"issue":"5","key":"2265_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mi.2012.134","volume":"6","author":"CB Collins","year":"2013","unstructured":"Collins CB, Aherne CM, Yeckes A, Pound K, Eltzschig HK, Jedlicka P, de Zoeten EF (2013) Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function. Mucosal Immunol 6(5):960\u2013971","journal-title":"Mucosal Immunol"},{"issue":"2","key":"2265_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00005-020-00573-7","volume":"68","author":"A Damasiewicz-Bodzek","year":"2020","unstructured":"Damasiewicz-Bodzek A, Szumska M, Tyrpie\u0144-Golder K (2020) Antibodies to heat shock proteins 90\u03b1 and 90\u03b2 in psoriasis. Arch Immunol Ther Exp (Warsz) 68(2):9","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"2265_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1471-4159.2006.04221.x","volume":"99","author":"C Dello Russo","year":"2006","unstructured":"Dello Russo C, Polak PE, Mercado PR, Spagnolo A, Sharp A, Murphy P et al (2006) The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem 99(5):1351\u20131362","journal-title":"J Neurochem"},{"issue":"3","key":"2265_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/1523-1747.ep12466250","volume":"96","author":"MJ Edwards","year":"1991","unstructured":"Edwards MJ, Marks R, Dykes PJ, Merrett VR, Morgan HE, O\u2019Donovan MR (1991) Heat shock proteins in cultured human keratinocytes and fibroblasts. J Invest Dermatol 96(3):392\u2013396","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2265_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/exd.14302","volume":"30","author":"RS Hansen","year":"2021","unstructured":"Hansen RS, Thuesen KKH, Bregnh\u00f8j A, Moldovan LI, Kristensen LS, Grek CL et al (2021) The HSP90 inhibitor RGRN-305 exhibits strong immunomodulatory effects in human keratinocytes. Exp Dermatol 30(6):773\u2013781","journal-title":"Exp Dermatol"},{"issue":"7","key":"2265_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103818","volume":"24","author":"N Heidari","year":"2025","unstructured":"Heidari N, Heidari A, Eghbali S, Pishraft-Sabet H, Hajikarim-Hamedani A, Ghane Y et al (2025) The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials. Autoimmun Rev 24(7):103818","journal-title":"Autoimmun Rev"},{"key":"2265_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092560","author":"A Hoter","year":"2018","unstructured":"Hoter A, El-Sabban ME, Naim HY (2018) The HSP90 family: structure, regulation, function, and implications in health and disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19092560","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2265_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jaad.2013.12.002","volume":"70","author":"M Kakeda","year":"2014","unstructured":"Kakeda M, Arock M, Schlapbach C, Yawalkar N (2014) Increased expression of heat shock protein 90 in keratinocytes and mast cells in patients with psoriasis. J Am Acad Dermatol 70(4):683\u201390.e1","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2265_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA et al (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14(1):105\u2013111","journal-title":"Cell Stress Chaperones"},{"key":"2265_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179366","author":"A Lubkowska","year":"2021","unstructured":"Lubkowska A, Pluta W, Stronska A, Lalko A (2021) Role of heat shock proteins (HSP70 and HSP90) in viral infection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22179366","journal-title":"Int J Mol Sci"},{"key":"2265_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88658.3","author":"S Maiti","year":"2023","unstructured":"Maiti S, Bhattacharya K, Wider D, Hany D, Panasenko O, Bernasconi L et al (2023) Hsf1 and the molecular chaperone Hsp90 support a \u201crewiring stress response\u201d leading to an adaptive cell size increase in chronic stress. Elife. https:\/\/doi.org\/10.7554\/eLife.88658.3","journal-title":"Elife"},{"issue":"5","key":"2265_CR19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos S, Mohebiany AN, Waisman A, Kurschus FC (2019) Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Invest Dermatol 139(5):1110\u20131117","journal-title":"J Invest Dermatol"},{"issue":"12","key":"2265_CR20","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1002\/art.24047","volume":"58","author":"JW Rice","year":"2008","unstructured":"Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE et al (2008) Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 58(12):3765\u20133775","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2265_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/cmi.2012.5","volume":"9","author":"SK Shimp 3rd","year":"2012","unstructured":"Shimp SK 3rd, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL et al (2012) Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL\/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol 9(3):255\u2013266","journal-title":"Cell Mol Immunol"},{"key":"2265_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810152","author":"SN Shirley","year":"2024","unstructured":"Shirley SN, Watson AE, Yusuf N (2024) Pathogenesis of inflammation in skin disease: from molecular mechanisms to pathology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251810152","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2265_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/15748928113089990031","volume":"9","author":"K Sidera","year":"2014","unstructured":"Sidera K, Patsavoudi E (2014) HSP90 inhibitors: current development and potential in cancer therapy. Recent Pat Anticancer Drug Discov 9(1):1\u201320","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"2265_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.102666","author":"LM Silbermann","year":"2024","unstructured":"Silbermann LM, Vermeer B, Schmid S, Tych K (2024) The known unknowns of the Hsp90 chaperone. Elife. https:\/\/doi.org\/10.7554\/eLife.102666","journal-title":"Elife"},{"issue":"6","key":"2265_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12192-021-01238-w","volume":"26","author":"K Sitko","year":"2021","unstructured":"Sitko K, Bednarek M, Mantej J, Trzeciak M, Tukaj S (2021) Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis. Cell Stress Chaperones 26(6):1001\u20131007","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"2265_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri749","volume":"2","author":"P Srivastava","year":"2002","unstructured":"Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2(3):185\u2013194","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2265_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2340\/00015555-1838","volume":"94","author":"K Stenderup","year":"2014","unstructured":"Stenderup K, Rosada C, Gavillet B, Vuagniaux G, Dam TN (2014) Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model. Acta Derm Venereol 94(6):672\u2013676","journal-title":"Acta Derm Venereol"},{"key":"2265_CR28","unstructured":"Storkanova H, Storkanova L, Navratilova A, Becvar V, Hulejova H, Oreska S, et al. (2021) Inhibition of Hsp90 counteracts the established experimental dermal fibrosis induced by bleomycin. Biomedicines. 9(6)"},{"key":"2265_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081153","author":"S Tukaj","year":"2022","unstructured":"Tukaj S, Sitko K (2022) Heat shock protein 90 (Hsp90) and Hsp70 as potential therapeutic targets in autoimmune skin diseases. Biomolecules. https:\/\/doi.org\/10.3390\/biom12081153","journal-title":"Biomolecules"},{"issue":"2","key":"2265_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12192-016-0670-z","volume":"21","author":"S Tukaj","year":"2016","unstructured":"Tukaj S, W\u0119grzyn G (2016) Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones 21(2):213\u2013218","journal-title":"Cell Stress Chaperones"},{"issue":"7","key":"2265_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070496","volume":"8","author":"S Tukaj","year":"2013","unstructured":"Tukaj S, Kleszczynski K, Vafia K, Groth S, Meyersburg D, Trzonkowski P et al (2013) Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid. PLoS ONE 8(7):e70496","journal-title":"PLoS ONE"},{"issue":"6","key":"2265_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/exd.12680","volume":"24","author":"S Tukaj","year":"2015","unstructured":"Tukaj S, Hellberg L, Ueck C, Hansel M, Samavedam U, Zillikens D et al (2015) Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. Exp Dermatol 24(6):471\u2013473","journal-title":"Exp Dermatol"},{"issue":"2","key":"2265_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00176-22","volume":"88","author":"AC Wickramaratne","year":"2024","unstructured":"Wickramaratne AC, Wickner S, Kravats AN (2024) Hsp90, a team player in protein quality control and the stress response in bacteria. Microbiol Mol Biol Rev 88(2):e0017622","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"2265_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4049\/jimmunol.1000222","volume":"186","author":"TJ Yun","year":"2011","unstructured":"Yun TJ, Harning EK, Giza K, Rabah D, Li P, Arndt JW et al (2011) EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity. J Immunol 186(1):563\u2013575","journal-title":"J Immunol"},{"issue":"10","key":"2265_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2174\/1389450123666220408101544","volume":"23","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li S, Li Z, Cheng L, Liu Z, Wang C (2022) The therapeutic potential of targeting Hsp90-Cdc37 interactions in several diseases. Curr Drug Targets 23(10):1023\u20131038","journal-title":"Curr Drug Targets"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02265-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:16:38Z","timestamp":1781745398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2265"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02265-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}